In general, the interaction between PD-L1, expressed in cancer cells, and PD-1, a T-cell membrane protein, inhibits CD8+ cytotoxic T-lymphocyte survival and proliferation and affects their function, ultimately suppressing the immune response and inducing immune tolerance of cancer [13]. This evidence concerns the gene CD8A and cancer.